Global Oncology Drugs Market 2026-2030
Global Oncology Drugs Market 2026-2030 The global oncology drugs market is forecasted to grow by USD 201568.1 mn during 2025-2030, accelerating at a CAGR of 11.6% during the forecast period. The r... もっと見る
SummaryGlobal Oncology Drugs Market 2026-2030The global oncology drugs market is forecasted to grow by USD 201568.1 mn during 2025-2030, accelerating at a CAGR of 11.6% during the forecast period. The report on the global oncology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of malignancies and aging demographics, accelerated innovation in precision medicine and novel modalities, expanding access and strategic clinical combinations. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit - Technavio's global oncology drugs market is segmented as below: By Therapy • Targeted therapy • Immunotherapy and hormonal therapy • Chemotherapy By Distribution Channel • Hospital pharmacies • Retail pharmacies • Online pharmacies By Form Factor • Solid • Injectable • Liquid By Indication • Blood cancer • Breast cancer • Lung cancer • Colorectal cancer • Others Geography • North America • US • Canada • Mexico • Europe • Germany • France • UK • Italy • Spain • The Netherlands • Asia • Rest of World (ROW) • Rest of World (ROW) This study identifies the precision medicine and biomarker-driven therapeutics as one of the prime reasons driving the global oncology drugs market growth during the next few years. Also, expansion of novel immunotherapy modalities and integration of ai in oncology care will lead to sizable demand in the market. The report on the global oncology drugs market covers the following areas: • Global oncology drugs market sizing • Global oncology drugs market forecast • Global oncology drugs market industry analysis The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global oncology drugs market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, BeiGene Ltd., Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Incyte Corp., Ipsen Pharma, Johnson and Johnson, Legend Biotech Corp., MacroGenics Inc., Merck KGaA, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Ltd.. Also, the global oncology drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities. The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth. Table of Contents1 Executive Summary1.1 Market overview • Executive Summary - Chart on Market Overview • Executive Summary - Data Table on Market Overview • Executive Summary - Chart on Global Market Characteristics • Executive Summary - Chart on Market by Geography • Executive Summary - Chart on Market Segmentation by Therapy • Executive Summary - Chart on Market Segmentation by Distribution Channel • Executive Summary - Chart on Market Segmentation by Form Factor • Executive Summary - Chart on Market Segmentation by Indication • Executive Summary - Chart on Incremental Growth • Executive Summary - Data Table on Incremental Growth • Executive Summary - Chart on Company Market Positioning 2 Technavio Analysis 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 2.2 Criticality of inputs and Factors of differentiation • Chart on Overview on criticality of inputs and factors of differentiation 2.3 Factors of disruption • Chart on Overview on factors of disruption 2.4 Impact of drivers and challenges • Chart on Impact of drivers and challenges in 2025 and 2030 3 Market Landscape 3.1 Market ecosystem • Chart on Parent Market • Data Table on - Parent Market 3.2 Market characteristics • Chart on Market characteristics analysis 3.3 Value chain analysis • Chart on Value chain analysis 4 Market Sizing 4.1 Market definition • Data Table on Offerings of companies included in the market definition 4.2 Market segment analysis • Market segments 4.3 Market size 2025 4.4 Market outlook: Forecast for 2025-2030 • Chart on Global - Market size and forecast 2025-2030 ($ million) • Data Table on Global - Market size and forecast 2025-2030 ($ million) • Chart on Global Market: Year-over-year growth 2025-2030 (%) • Data Table on Global Market: Year-over-year growth 2025-2030 (%) 5 Historic Market Size 5.1 Global Oncology Drugs Market 2020 - 2024 • Historic Market Size - Data Table on Global Oncology Drugs Market 2020 - 2024 ($ million) 5.2 Therapy segment analysis 2020 - 2024 • Historic Market Size - Therapy Segment 2020 - 2024 ($ million) 5.3 Distribution Channel segment analysis 2020 - 2024 • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million) 5.4 Form Factor segment analysis 2020 - 2024 • Historic Market Size - Form Factor Segment 2020 - 2024 ($ million) 5.5 Indication segment analysis 2020 - 2024 • Historic Market Size - Indication Segment 2020 - 2024 ($ million) 5.6 Geography segment analysis 2020 - 2024 • Historic Market Size - Geography Segment 2020 - 2024 ($ million) 5.7 Country segment analysis 2020 - 2024 • Historic Market Size - Country Segment 2020 - 2024 ($ million) 6 Qualitative Analysis 6.1 Impact of AI on global oncology drugs market 6.2 Impact of geopolitical conflicts on global oncology drugs market 7 Five Forces Analysis 7.1 Five forces summary • Five forces analysis - Comparison between 2025 and 2030 7.2 Bargaining power of buyers • Bargaining power of buyers - Impact of key factors 2025 and 2030 7.3 Bargaining power of suppliers • Bargaining power of suppliers - Impact of key factors in 2025 and 2030 7.4 Threat of new entrants • Threat of new entrants - Impact of key factors in 2025 and 2030 7.5 Threat of substitutes • Threat of substitutes - Impact of key factors in 2025 and 2030 7.6 Threat of rivalry • Threat of rivalry - Impact of key factors in 2025 and 2030 7.7 Market condition • Chart on Market condition - Five forces 2025 and 2030 8 Market Segmentation by Therapy 8.1 Market segments • Chart on Therapy - Market share 2025-2030 (%) • Data Table on Therapy - Market share 2025-2030 (%) 8.2 Comparison by Therapy • Chart on Comparison by Therapy • Data Table on Comparison by Therapy 8.3 Targeted therapy - Market size and forecast 2025-2030 • Chart on Targeted therapy - Market size and forecast 2025-2030 ($ million) • Data Table on Targeted therapy - Market size and forecast 2025-2030 ($ million) • Chart on Targeted therapy - Year-over-year growth 2025-2030 (%) • Data Table on Targeted therapy - Year-over-year growth 2025-2030 (%) 8.4 Immunotherapy and hormonal therapy - Market size and forecast 2025-2030 • Chart on Immunotherapy and hormonal therapy - Market size and forecast 2025-2030 ($ million) • Data Table on Immunotherapy and hormonal therapy - Market size and forecast 2025-2030 ($ million) • Chart on Immunotherapy and hormonal therapy - Year-over-year growth 2025-2030 (%) • Data Table on Immunotherapy and hormonal therapy - Year-over-year growth 2025-2030 (%) 8.5 Chemotherapy - Market size and forecast 2025-2030 • Chart on Chemotherapy - Market size and forecast 2025-2030 ($ million) • Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ million) • Chart on Chemotherapy - Year-over-year growth 2025-2030 (%) • Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%) 8.6 Market opportunity by Therapy • Market opportunity by Therapy ($ million) • Data Table on Market opportunity by Therapy ($ million) 9 Market Segmentation by Distribution Channel 9.1 Market segments • Chart on Distribution Channel - Market share 2025-2030 (%) • Data Table on Distribution Channel - Market share 2025-2030 (%) 9.2 Comparison by Distribution Channel • Chart on Comparison by Distribution Channel • Data Table on Comparison by Distribution Channel 9.3 Hospital pharmacies - Market size and forecast 2025-2030 • Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million) • Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million) • Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%) • Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%) 9.4 Retail pharmacies - Market size and forecast 2025-2030 • Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million) • Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million) • Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%) • Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%) 9.5 Online pharmacies - Market size and forecast 2025-2030 • Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million) • Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million) • Chart on Online pharmacies - Year-over-year growth 2025-2030 (%) • Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%) 9.6 Market opportunity by Distribution Channel • Market opportunity by Distribution Channel ($ million) • Data Table on Market opportunity by Distribution Channel ($ million) 10 Market Segmentation by Form Factor 10.1 Market segments • Chart on Form Factor - Market share 2025-2030 (%) • Data Table on Form Factor - Market share 2025-2030 (%) 10.2 Comparison by Form Factor • Chart on Comparison by Form Factor • Data Table on Comparison by Form Factor 10.3 Solid - Market size and forecast 2025-2030 • Chart on Solid - Market size and forecast 2025-2030 ($ million) • Data Table on Solid - Market size and forecast 2025-2030 ($ million) • Chart on Solid - Year-over-year growth 2025-2030 (%) • Data Table on Solid - Year-over-year growth 2025-2030 (%) 10.4 Injectable - Market size and forecast 2025-2030 • Chart on Injectable - Market size and forecast 2025-2030 ($ million) • Data Table on Injectable - Market size and forecast 2025-2030 ($ million) • Chart on Injectable - Year-over-year growth 2025-2030 (%) • Data Table on Injectable - Year-over-year growth 2025-2030 (%) 10.5 Liquid - Market size and forecast 2025-2030 • Chart on Liquid - Market size and forecast 2025-2030 ($ million) • Data Table on Liquid - Market size and forecast 2025-2030 ($ million) • Chart on Liquid - Year-over-year growth 2025-2030 (%) • Data Table on Liquid - Year-over-year growth 2025-2030 (%) 10.6 Market opportunity by Form Factor • Market opportunity by Form Factor ($ million) • Data Table on Market opportunity by Form Factor ($ million) 11 Market Segmentation by Indication 11.1 Market segments • Chart on Indication - Market share 2025-2030 (%) • Data Table on Indication - Market share 2025-2030 (%) 11.2 Comparison by Indication • Chart on Comparison by Indication • Data Table on Comparison by Indication 11.3 Blood cancer - Market size and forecast 2025-2030 • Chart on Blood cancer - Market size and forecast 2025-2030 ($ million) • Data Table on Blood cancer - Market size and forecast 2025-2030 ($ million) • Chart on Blood cancer - Year-over-year growth 2025-2030 (%) • Data Table on Blood cancer - Year-over-year growth 2025-2030 (%) 11.4 Breast cancer - Market size and forecast 2025-2030 • Chart on Breast cancer - Market size and forecast 2025-2030 ($ million) • Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million) • Chart on Breast cancer - Year-over-year growth 2025-2030 (%) • Data Table on Breast cancer - Year-over-year growth 2025-2030 (%) 11.5 Lung cancer - Market size and forecast 2025-2030 • Chart on Lung cancer - Market size and forecast 2025-2030 ($ million) • Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million) • Chart on Lung cancer - Year-over-year growth 2025-2030 (%) • Data Table on Lung cancer - Year-over-year growth 2025-2030 (%) 11.6 Colorectal cancer - Market size and forecast 2025-2030 • Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million) • Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million) • Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%) • Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%) 11.7 Others - Market size and forecast 2025-2030 • Chart on Others - Market size and forecast 2025-2030 ($ million) • Data Table on Others - Market size and forecast 2025-2030 ($ million) • Chart on Others - Year-over-year growth 2025-2030 (%) • Data Table on Others - Year-over-year growth 2025-2030 (%) 11.8 Market opportunity by Indication • Market opportunity by Indication ($ million) • Data Table on Market opportunity by Indication ($ million) 12 Customer Landscape 12.1 Customer landscape overview • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 13 Geographic Landscape 13.1 Geographic segmentation • Chart on Market share by geography 2025-2030 (%) • Data Table on Market share by geography 2025-2030 (%) 13.2 Geographic comparison • Chart on Geographic comparison • Data Table on Geographic comparison 13.3 North America - Market size and forecast 2025-2030 • Chart on North America - Market size and forecast 2025-2030 ($ million) • Data Table on North America - Market size and forecast 2025-2030 ($ million) • Chart on North America - Year-over-year growth 2025-2030 (%) • Data Table on North America - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - North America • Data Table on Regional Comparison - North America 13.3.1 US - Market size and forecast 2025-2030 • Chart on US - Market size and forecast 2025-2030 ($ million) • Data Table on US - Market size and forecast 2025-2030 ($ million) • Chart on US - Year-over-year growth 2025-2030 (%) • Data Table on US - Year-over-year growth 2025-2030 (%) 13.3.2 Canada - Market size and forecast 2025-2030 • Chart on Canada - Market size and forecast 2025-2030 ($ million) • Data Table on Canada - Market size and forecast 2025-2030 ($ million) • Chart on Canada - Year-over-year growth 2025-2030 (%) • Data Table on Canada - Year-over-year growth 2025-2030 (%) 13.3.3 Mexico - Market size and forecast 2025-2030 • Chart on Mexico - Market size and forecast 2025-2030 ($ million) • Data Table on Mexico - Market size and forecast 2025-2030 ($ million) • Chart on Mexico - Year-over-year growth 2025-2030 (%) • Data Table on Mexico - Year-over-year growth 2025-2030 (%) 13.4 Europe - Market size and forecast 2025-2030 • Chart on Europe - Market size and forecast 2025-2030 ($ million) • Data Table on Europe - Market size and forecast 2025-2030 ($ million) • Chart on Europe - Year-over-year growth 2025-2030 (%) • Data Table on Europe - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - Europe • Data Table on Regional Comparison - Europe 13.4.1 Germany - Market size and forecast 2025-2030 • Chart on Germany - Market size and forecast 2025-2030 ($ million) • Data Table on Germany - Market size and forecast 2025-2030 ($ million) • Chart on Germany - Year-over-year growth 2025-2030 (%) • Data Table on Germany - Year-over-year growth 2025-2030 (%) 13.4.2 France - Market size and forecast 2025-2030 • Chart on France - Market size and forecast 2025-2030 ($ million) • Data Table on France - Market size and forecast 2025-2030 ($ million) • Chart on France - Year-over-year growth 2025-2030 (%) • Data Table on France - Year-over-year growth 2025-2030 (%) 13.4.3 UK - Market size and forecast 2025-2030 • Chart on UK - Market size and forecast 2025-2030 ($ million) • Data Table on UK - Market size and forecast 2025-2030 ($ million) • Chart on UK - Year-over-year growth 2025-2030 (%) • Data Table on UK - Year-over-year growth 2025-2030 (%) 13.4.4 Italy - Market size and forecast 2025-2030 • Chart on Italy - Market size and forecast 2025-2030 ($ million) • Data Table on Italy - Market size and forecast 2025-2030 ($ million) • Chart on Italy - Year-over-year growth 2025-2030 (%) • Data Table on Italy - Year-over-year growth 2025-2030 (%) 13.4.5 Spain - Market size and forecast 2025-2030 • Chart on Spain - Market size and forecast 2025-2030 ($ million) • Data Table on Spain - Market size and forecast 2025-2030 ($ million) • Chart on Spain - Year-over-year growth 2025-2030 (%) • Data Table on Spain - Year-over-year growth 2025-2030 (%) 13.4.6 The Netherlands - Market size and forecast 2025-2030 • Chart on The Netherlands - Market size and forecast 2025-2030 ($ million) • Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million) • Chart on The Netherlands - Year-over-year growth 2025-2030 (%) • Data Table on The Netherlands - Year-over-year growth 2025-2030 (%) 13.5 Asia - Market size and forecast 2025-2030 • Chart on Asia - Market size and forecast 2025-2030 ($ million) • Data Table on Asia - Market size and forecast 2025-2030 ($ million) • Chart on Asia - Year-over-year growth 2025-2030 (%) • Data Table on Asia - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - Asia • Data Table on Regional Comparison - Asia 13.5.1 China - Market size and forecast 2025-2030 • Chart on China - Market size and forecast 2025-2030 ($ million) • Data Table on China - Market size and forecast 2025-2030 ($ million) • Chart on China - Year-over-year growth 2025-2030 (%) • Data Table on China - Year-over-year growth 2025-2030 (%) 13.5.2 Japan - Market size and forecast 2025-2030 • Chart on Japan - Market size and forecast 2025-2030 ($ million) • Data Table on Japan - Market size and forecast 2025-2030 ($ million) • Chart on Japan - Year-over-year growth 2025-2030 (%) • Data Table on Japan - Year-over-year growth 2025-2030 (%) 13.5.3 India - Market size and forecast 2025-2030 • Chart on India - Market size and forecast 2025-2030 ($ million) • Data Table on India - Market size and forecast 2025-2030 ($ million) • Chart on India - Year-over-year growth 2025-2030 (%) • Data Table on India - Year-over-year growth 2025-2030 (%) 13.5.4 South Korea - Market size and forecast 2025-2030 • Chart on South Korea - Market size and forecast 2025-2030 ($ million) • Data Table on South Korea - Market size and forecast 2025-2030 ($ million) • Chart on South Korea - Year-over-year growth 2025-2030 (%) • Data Table on South Korea - Year-over-year growth 2025-2030 (%) 13.5.5 Taiwan - Market size and forecast 2025-2030 • Chart on Taiwan - Market size and forecast 2025-2030 ($ million) • Data Table on Taiwan - Market size and forecast 2025-2030 ($ million) • Chart on Taiwan - Year-over-year growth 2025-2030 (%) • Data Table on Taiwan - Year-over-year growth 2025-2030 (%) 13.5.6 Singapore - Market size and forecast 2025-2030 • Chart on Singapore - Market size and forecast 2025-2030 ($ million) • Data Table on Singapore - Market size and forecast 2025-2030 ($ million) • Chart on Singapore - Year-over-year growth 2025-2030 (%) • Data Table on Singapore - Year-over-year growth 2025-2030 (%) 13.6 Rest of World (ROW) - Market size and forecast 2025-2030 • Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) • Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) • Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) • Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) • Chart on Regional Comparison - Rest of World (ROW) • Data Table on Regional Comparison - Rest of World (ROW) 13.6.1 Brazil - Market size and forecast 2025-2030 • Chart on Brazil - Market size and forecast 2025-2030 ($ million) • Data Table on Brazil - Market size and forecast 2025-2030 ($ million) • Chart on Brazil - Year-over-year growth 2025-2030 (%) • Data Table on Brazil - Year-over-year growth 2025-2030 (%) 13.6.2 Australia - Market size and forecast 2025-2030 • Chart on Australia - Market size and forecast 2025-2030 ($ million) • Data Table on Australia - Market size and forecast 2025-2030 ($ million) • Chart on Australia - Year-over-year growth 2025-2030 (%) • Data Table on Australia - Year-over-year growth 2025-2030 (%) 13.6.3 Saudi Arabia - Market size and forecast 2025-2030 • Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million) • Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million) • Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%) • Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%) 13.6.4 Argentina - Market size and forecast 2025-2030 • Chart on Argentina - Market size and forecast 2025-2030 ($ million) • Data Table on Argentina - Market size and forecast 2025-2030 ($ million) • Chart on Argentina - Year-over-year growth 2025-2030 (%) • Data Table on Argentina - Year-over-year growth 2025-2030 (%) 13.6.5 South Africa - Market size and forecast 2025-2030 • Chart on South Africa - Market size and forecast 2025-2030 ($ million) • Data Table on South Africa - Market size and forecast 2025-2030 ($ million) • Chart on South Africa - Year-over-year growth 2025-2030 (%) • Data Table on South Africa - Year-over-year growth 2025-2030 (%) 13.6.6 UAE - Market size and forecast 2025-2030 • Chart on UAE - Market size and forecast 2025-2030 ($ million) • Data Table on UAE - Market size and forecast 2025-2030 ($ million) • Chart on UAE - Year-over-year growth 2025-2030 (%) • Data Table on UAE - Year-over-year growth 2025-2030 (%) 13.6.7 Chile - Market size and forecast 2025-2030 • Chart on Chile - Market size and forecast 2025-2030 ($ million) • Data Table on Chile - Market size and forecast 2025-2030 ($ million) • Chart on Chile - Year-over-year growth 2025-2030 (%) • Data Table on Chile - Year-over-year growth 2025-2030 (%) 13.6.8 Turkey - Market size and forecast 2025-2030 • Chart on Turkey - Market size and forecast 2025-2030 ($ million) • Data Table on Turkey - Market size and forecast 2025-2030 ($ million) • Chart on Turkey - Year-over-year growth 2025-2030 (%) • Data Table on Turkey - Year-over-year growth 2025-2030 (%) 13.7 Market opportunity by geography • Market opportunity by geography ($ million) • Data Tables on Market opportunity by geography ($ million) 14 Drivers, Challenges, and Opportunity 14.1 Market drivers • Rising prevalence of malignancies and aging demographics • Accelerated innovation in precision medicine and novel modalities • Expanding access and strategic clinical combinations 14.2 Market challenges • Complexity and operational constraints in clinical trial execution • Access barriers and stringent cost-effectiveness evaluations • Manufacturing resilience and supply chain vulnerabilities 14.3 Impact of drivers and challenges • Impact of drivers and challenges in 2025 and 2030 14.4 Market opportunities • Precision medicine and biomarker-driven therapeutics • Expansion of novel immunotherapy modalities • Integration of AI in oncology care 15 Competitive Landscape 15.1 Overview 15.2 Competitive Landscape • Overview on criticality of inputs and factors of differentiation 15.3 Landscape disruption • Overview on factors of disruption 15.4 Industry risks • Impact of key risks on business 16 Competitive Analysis 16.1 Companies profiled • Companies covered 16.2 Company ranking index • Company ranking index 16.3 Market positioning of companies • Matrix on companies position and classification 16.4 AbbVie Inc. • AbbVie Inc. - Overview • AbbVie Inc. - Business segments • AbbVie Inc. - Key news • AbbVie Inc. - Key offerings • AbbVie Inc. - Segment focus • SWOT 16.5 Amgen Inc. • Amgen Inc. - Overview • Amgen Inc. - Product / Service • Amgen Inc. - Key news • Amgen Inc. - Key offerings • SWOT 16.6 AstraZeneca Plc • AstraZeneca Plc - Overview • AstraZeneca Plc - Business segments • AstraZeneca Plc - Key news • AstraZeneca Plc - Key offerings • AstraZeneca Plc - Segment focus • SWOT 16.7 Bayer AG • Bayer AG - Overview • Bayer AG - Business segments • Bayer AG - Key news • Bayer AG - Key offerings • Bayer AG - Segment focus • SWOT 16.8 Bristol Myers Squibb Co. • Bristol Myers Squibb Co. - Overview • Bristol Myers Squibb Co. - Product / Service • Bristol Myers Squibb Co. - Key news • Bristol Myers Squibb Co. - Key offerings • SWOT 16.9 Daiichi Sankyo Co. Ltd. • Daiichi Sankyo Co. Ltd. - Overview • Daiichi Sankyo Co. Ltd. - Business segments • Daiichi Sankyo Co. Ltd. - Key news • Daiichi Sankyo Co. Ltd. - Key offerings • Daiichi Sankyo Co. Ltd. - Segment focus • SWOT 16.10 Eli Lilly and Co. • Eli Lilly and Co. - Overview • Eli Lilly and Co. - Product / Service • Eli Lilly and Co. - Key news • Eli Lilly and Co. - Key offerings • SWOT 16.11 F. Hoffmann La Roche Ltd. • F. Hoffmann La Roche Ltd. - Overview • F. Hoffmann La Roche Ltd. - Business segments • F. Hoffmann La Roche Ltd. - Key news • F. Hoffmann La Roche Ltd. - Key offerings • F. Hoffmann La Roche Ltd. - Segment focus • SWOT 16.12 GlaxoSmithKline Plc • GlaxoSmithKline Plc - Overview • GlaxoSmithKline Plc - Business segments • GlaxoSmithKline Plc - Key news • GlaxoSmithKline Plc - Key offerings • GlaxoSmithKline Plc - Segment focus • SWOT 16.13 Johnson and Johnson • Johnson and Johnson - Overview • Johnson and Johnson - Business segments • Johnson and Johnson - Key news • Johnson and Johnson - Key offerings • Johnson and Johnson - Segment focus • SWOT 16.14 Merck KGaA • Merck KGaA - Overview • Merck KGaA - Business segments • Merck KGaA - Key news • Merck KGaA - Key offerings • Merck KGaA - Segment focus • SWOT 16.15 Novartis AG • Novartis AG - Overview • Novartis AG - Business segments • Novartis AG - Key news • Novartis AG - Key offerings • Novartis AG - Segment focus • SWOT 16.16 Pfizer Inc. • Pfizer Inc. - Overview • Pfizer Inc. - Business segments • Pfizer Inc. - Key news • Pfizer Inc. - Key offerings • Pfizer Inc. - Segment focus • SWOT 16.17 Sanofi SA • Sanofi SA - Overview • Sanofi SA - Business segments • Sanofi SA - Key news • Sanofi SA - Key offerings • Sanofi SA - Segment focus • SWOT 16.18 Takeda Pharmaceutical Ltd. • Takeda Pharmaceutical Ltd. - Overview • Takeda Pharmaceutical Ltd. - Business segments • Takeda Pharmaceutical Ltd. - Key news • Takeda Pharmaceutical Ltd. - Key offerings • Takeda Pharmaceutical Ltd. - Segment focus • SWOT 17 Appendix 17.1 Scope of the report • Market definition • Objectives • Notes and caveats 17.2 Inclusions and exclusions checklist • Inclusions checklist • Exclusions checklist 17.3 Currency conversion rates for US$ • Currency conversion rates for US$ 17.4 Research methodology • Research methodology 17.5 Data procurement • Information sources 17.6 Data validation • Data validation 17.7 Validation techniques employed for market sizing • Validation techniques employed for market sizing 17.8 Data synthesis • Data synthesis 17.9 360 degree market analysis • 360 degree market analysis 17.10 List of abbreviations • List of abbreviations List of Tables/GraphsExhibits1: Executive Summary - Chart on Market OverviewExhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market by Geography Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel Exhibits7: Executive Summary - Chart on Market Segmentation by Form Factor Exhibits8: Executive Summary - Chart on Market Segmentation by Indication Exhibits9: Executive Summary - Chart on Incremental Growth Exhibits10: Executive Summary - Data Table on Incremental Growth Exhibits11: Executive Summary - Chart on Company Market Positioning Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits13: Chart on Overview on criticality of inputs and factors of differentiation Exhibits14: Chart on Overview on factors of disruption Exhibits15: Chart on Impact of drivers and challenges in 2025 and 2030 Exhibits16: Chart on Parent Market Exhibits17: Data Table on - Parent Market Exhibits18: Chart on Market characteristics analysis Exhibits19: Chart on Value chain analysis Exhibits20: Data Table on Offerings of companies included in the market definition Exhibits21: Market segments Exhibits22: Chart on Global - Market size and forecast 2025-2030 ($ million) Exhibits23: Data Table on Global - Market size and forecast 2025-2030 ($ million) Exhibits24: Chart on Global Market: Year-over-year growth 2025-2030 (%) Exhibits25: Data Table on Global Market: Year-over-year growth 2025-2030 (%) Exhibits26: Historic Market Size - Data Table on Global Oncology Drugs Market 2020 - 2024 ($ million) Exhibits27: Historic Market Size - Therapy Segment 2020 - 2024 ($ million) Exhibits28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million) Exhibits29: Historic Market Size - Form Factor Segment 2020 - 2024 ($ million) Exhibits30: Historic Market Size - Indication Segment 2020 - 2024 ($ million) Exhibits31: Historic Market Size - Geography Segment 2020 - 2024 ($ million) Exhibits32: Historic Market Size - Country Segment 2020 - 2024 ($ million) Exhibits33: Five forces analysis - Comparison between 2025 and 2030 Exhibits34: Bargaining power of buyers - Impact of key factors 2025 and 2030 Exhibits35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030 Exhibits36: Threat of new entrants - Impact of key factors in 2025 and 2030 Exhibits37: Threat of substitutes - Impact of key factors in 2025 and 2030 Exhibits38: Threat of rivalry - Impact of key factors in 2025 and 2030 Exhibits39: Chart on Market condition - Five forces 2025 and 2030 Exhibits40: Chart on Therapy - Market share 2025-2030 (%) Exhibits41: Data Table on Therapy - Market share 2025-2030 (%) Exhibits42: Chart on Comparison by Therapy Exhibits43: Data Table on Comparison by Therapy Exhibits44: Chart on Targeted therapy - Market size and forecast 2025-2030 ($ million) Exhibits45: Data Table on Targeted therapy - Market size and forecast 2025-2030 ($ million) Exhibits46: Chart on Targeted therapy - Year-over-year growth 2025-2030 (%) Exhibits47: Data Table on Targeted therapy - Year-over-year growth 2025-2030 (%) Exhibits48: Chart on Immunotherapy and hormonal therapy - Market size and forecast 2025-2030 ($ million) Exhibits49: Data Table on Immunotherapy and hormonal therapy - Market size and forecast 2025-2030 ($ million) Exhibits50: Chart on Immunotherapy and hormonal therapy - Year-over-year growth 2025-2030 (%) Exhibits51: Data Table on Immunotherapy and hormonal therapy - Year-over-year growth 2025-2030 (%) Exhibits52: Chart on Chemotherapy - Market size and forecast 2025-2030 ($ million) Exhibits53: Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ million) Exhibits54: Chart on Chemotherapy - Year-over-year growth 2025-2030 (%) Exhibits55: Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%) Exhibits56: Market opportunity by Therapy ($ million) Exhibits57: Data Table on Market opportunity by Therapy ($ million) Exhibits58: Chart on Distribution Channel - Market share 2025-2030 (%) Exhibits59: Data Table on Distribution Channel - Market share 2025-2030 (%) Exhibits60: Chart on Comparison by Distribution Channel Exhibits61: Data Table on Comparison by Distribution Channel Exhibits62: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million) Exhibits63: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million) Exhibits64: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%) Exhibits65: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%) Exhibits66: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million) Exhibits67: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million) Exhibits68: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%) Exhibits69: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%) Exhibits70: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million) Exhibits71: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million) Exhibits72: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%) Exhibits73: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%) Exhibits74: Market opportunity by Distribution Channel ($ million) Exhibits75: Data Table on Market opportunity by Distribution Channel ($ million) Exhibits76: Chart on Form Factor - Market share 2025-2030 (%) Exhibits77: Data Table on Form Factor - Market share 2025-2030 (%) Exhibits78: Chart on Comparison by Form Factor Exhibits79: Data Table on Comparison by Form Factor Exhibits80: Chart on Solid - Market size and forecast 2025-2030 ($ million) Exhibits81: Data Table on Solid - Market size and forecast 2025-2030 ($ million) Exhibits82: Chart on Solid - Year-over-year growth 2025-2030 (%) Exhibits83: Data Table on Solid - Year-over-year growth 2025-2030 (%) Exhibits84: Chart on Injectable - Market size and forecast 2025-2030 ($ million) Exhibits85: Data Table on Injectable - Market size and forecast 2025-2030 ($ million) Exhibits86: Chart on Injectable - Year-over-year growth 2025-2030 (%) Exhibits87: Data Table on Injectable - Year-over-year growth 2025-2030 (%) Exhibits88: Chart on Liquid - Market size and forecast 2025-2030 ($ million) Exhibits89: Data Table on Liquid - Market size and forecast 2025-2030 ($ million) Exhibits90: Chart on Liquid - Year-over-year growth 2025-2030 (%) Exhibits91: Data Table on Liquid - Year-over-year growth 2025-2030 (%) Exhibits92: Market opportunity by Form Factor ($ million) Exhibits93: Data Table on Market opportunity by Form Factor ($ million) Exhibits94: Chart on Indication - Market share 2025-2030 (%) Exhibits95: Data Table on Indication - Market share 2025-2030 (%) Exhibits96: Chart on Comparison by Indication Exhibits97: Data Table on Comparison by Indication Exhibits98: Chart on Blood cancer - Market size and forecast 2025-2030 ($ million) Exhibits99: Data Table on Blood cancer - Market size and forecast 2025-2030 ($ million) Exhibits100: Chart on Blood cancer - Year-over-year growth 2025-2030 (%) Exhibits101: Data Table on Blood cancer - Year-over-year growth 2025-2030 (%) Exhibits102: Chart on Breast cancer - Market size and forecast 2025-2030 ($ million) Exhibits103: Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million) Exhibits104: Chart on Breast cancer - Year-over-year growth 2025-2030 (%) Exhibits105: Data Table on Breast cancer - Year-over-year growth 2025-2030 (%) Exhibits106: Chart on Lung cancer - Market size and forecast 2025-2030 ($ million) Exhibits107: Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million) Exhibits108: Chart on Lung cancer - Year-over-year growth 2025-2030 (%) Exhibits109: Data Table on Lung cancer - Year-over-year growth 2025-2030 (%) Exhibits110: Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million) Exhibits111: Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million) Exhibits112: Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%) Exhibits113: Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%) Exhibits114: Chart on Others - Market size and forecast 2025-2030 ($ million) Exhibits115: Data Table on Others - Market size and forecast 2025-2030 ($ million) Exhibits116: Chart on Others - Year-over-year growth 2025-2030 (%) Exhibits117: Data Table on Others - Year-over-year growth 2025-2030 (%) Exhibits118: Market opportunity by Indication ($ million) Exhibits119: Data Table on Market opportunity by Indication ($ million) Exhibits120: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits121: Chart on Market share by geography 2025-2030 (%) Exhibits122: Data Table on Market share by geography 2025-2030 (%) Exhibits123: Chart on Geographic comparison Exhibits124: Data Table on Geographic comparison Exhibits125: Chart on North America - Market size and forecast 2025-2030 ($ million) Exhibits126: Data Table on North America - Market size and forecast 2025-2030 ($ million) Exhibits127: Chart on North America - Year-over-year growth 2025-2030 (%) Exhibits128: Data Table on North America - Year-over-year growth 2025-2030 (%) Exhibits129: Chart on Regional Comparison - North America Exhibits130: Data Table on Regional Comparison - North America Exhibits131: Chart on US - Market size and forecast 2025-2030 ($ million) Exhibits132: Data Table on US - Market size and forecast 2025-2030 ($ million) Exhibits133: Chart on US - Year-over-year growth 2025-2030 (%) Exhibits134: Data Table on US - Year-over-year growth 2025-2030 (%) Exhibits135: Chart on Canada - Market size and forecast 2025-2030 ($ million) Exhibits136: Data Table on Canada - Market size and forecast 2025-2030 ($ million) Exhibits137: Chart on Canada - Year-over-year growth 2025-2030 (%) Exhibits138: Data Table on Canada - Year-over-year growth 2025-2030 (%) Exhibits139: Chart on Mexico - Market size and forecast 2025-2030 ($ million) Exhibits140: Data Table on Mexico - Market size and forecast 2025-2030 ($ million) Exhibits141: Chart on Mexico - Year-over-year growth 2025-2030 (%) Exhibits142: Data Table on Mexico - Year-over-year growth 2025-2030 (%) Exhibits143: Chart on Europe - Market size and forecast 2025-2030 ($ million) Exhibits144: Data Table on Europe - Market size and forecast 2025-2030 ($ million) Exhibits145: Chart on Europe - Year-over-year growth 2025-2030 (%) Exhibits146: Data Table on Europe - Year-over-year growth 2025-2030 (%) Exhibits147: Chart on Regional Comparison - Europe Exhibits148: Data Table on Regional Comparison - Europe Exhibits149: Chart on Germany - Market size and forecast 2025-2030 ($ million) Exhibits150: Data Table on Germany - Market size and forecast 2025-2030 ($ million) Exhibits151: Chart on Germany - Year-over-year growth 2025-2030 (%) Exhibits152: Data Table on Germany - Year-over-year growth 2025-2030 (%) Exhibits153: Chart on France - Market size and forecast 2025-2030 ($ million) Exhibits154: Data Table on France - Market size and forecast 2025-2030 ($ million) Exhibits155: Chart on France - Year-over-year growth 2025-2030 (%) Exhibits156: Data Table on France - Year-over-year growth 2025-2030 (%) Exhibits157: Chart on UK - Market size and forecast 2025-2030 ($ million) Exhibits158: Data Table on UK - Market size and forecast 2025-2030 ($ million) Exhibits159: Chart on UK - Year-over-year growth 2025-2030 (%) Exhibits160: Data Table on UK - Year-over-year growth 2025-2030 (%) Exhibits161: Chart on Italy - Market size and forecast 2025-2030 ($ million) Exhibits162: Data Table on Italy - Market size and forecast 2025-2030 ($ million) Exhibits163: Chart on Italy - Year-over-year growth 2025-2030 (%) Exhibits164: Data Table on Italy - Year-over-year growth 2025-2030 (%) Exhibits165: Chart on Spain - Market size and forecast 2025-2030 ($ million) Exhibits166: Data Table on Spain - Market size and forecast 2025-2030 ($ million) Exhibits167: Chart on Spain - Year-over-year growth 2025-2030 (%) Exhibits168: Data Table on Spain - Year-over-year growth 2025-2030 (%) Exhibits169: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million) Exhibits170: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million) Exhibits171: Chart on The Netherlands - Year-over-year growth 2025-2030 (%) Exhibits172: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%) Exhibits173: Chart on Asia - Market size and forecast 2025-2030 ($ million) Exhibits174: Data Table on Asia - Market size and forecast 2025-2030 ($ million) Exhibits175: Chart on Asia - Year-over-year growth 2025-2030 (%) Exhibits176: Data Table on Asia - Year-over-year growth 2025-2030 (%) Exhibits177: Chart on Regional Comparison - Asia Exhibits178: Data Table on Regional Comparison - Asia Exhibits179: Chart on China - Market size and forecast 2025-2030 ($ million) Exhibits180: Data Table on China - Market size and forecast 2025-2030 ($ million) Exhibits181: Chart on China - Year-over-year growth 2025-2030 (%) Exhibits182: Data Table on China - Year-over-year growth 2025-2030 (%) Exhibits183: Chart on Japan - Market size and forecast 2025-2030 ($ million) Exhibits184: Data Table on Japan - Market size and forecast 2025-2030 ($ million) Exhibits185: Chart on Japan - Year-over-year growth 2025-2030 (%) Exhibits186: Data Table on Japan - Year-over-year growth 2025-2030 (%) Exhibits187: Chart on India - Market size and forecast 2025-2030 ($ million) Exhibits188: Data Table on India - Market size and forecast 2025-2030 ($ million) Exhibits189: Chart on India - Year-over-year growth 2025-2030 (%) Exhibits190: Data Table on India - Year-over-year growth 2025-2030 (%) Exhibits191: Chart on South Korea - Market size and forecast 2025-2030 ($ million) Exhibits192: Data Table on South Korea - Market size and forecast 2025-2030 ($ million) Exhibits193: Chart on South Korea - Year-over-year growth 2025-2030 (%) Exhibits194: Data Table on South Korea - Year-over-year growth 2025-2030 (%) Exhibits195: Chart on Taiwan - Market size and forecast 2025-2030 ($ million) Exhibits196: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million) Exhibits197: Chart on Taiwan - Year-over-year growth 2025-2030 (%) Exhibits198: Data Table on Taiwan - Year-over-year growth 2025-2030 (%) Exhibits199: Chart on Singapore - Market size and forecast 2025-2030 ($ million) Exhibits200: Data Table on Singapore - Market size and forecast 2025-2030 ($ million) Exhibits201: Chart on Singapore - Year-over-year growth 2025-2030 (%) Exhibits202: Data Table on Singapore - Year-over-year growth 2025-2030 (%) Exhibits203: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) Exhibits204: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million) Exhibits205: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) Exhibits206: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%) Exhibits207: Chart on Regional Comparison - Rest of World (ROW) Exhibits208: Data Table on Regional Comparison - Rest of World (ROW) Exhibits209: Chart on Brazil - Market size and forecast 2025-2030 ($ million) Exhibits210: Data Table on Brazil - Market size and forecast 2025-2030 ($ million) Exhibits211: Chart on Brazil - Year-over-year growth 2025-2030 (%) Exhibits212: Data Table on Brazil - Year-over-year growth 2025-2030 (%) Exhibits213: Chart on Australia - Market size and forecast 2025-2030 ($ million) Exhibits214: Data Table on Australia - Market size and forecast 2025-2030 ($ million) Exhibits215: Chart on Australia - Year-over-year growth 2025-2030 (%) Exhibits216: Data Table on Australia - Year-over-year growth 2025-2030 (%) Exhibits217: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million) Exhibits218: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million) Exhibits219: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%) Exhibits220: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%) Exhibits221: Chart on Argentina - Market size and forecast 2025-2030 ($ million) Exhibits222: Data Table on Argentina - Market size and forecast 2025-2030 ($ million) Exhibits223: Chart on Argentina - Year-over-year growth 2025-2030 (%) Exhibits224: Data Table on Argentina - Year-over-year growth 2025-2030 (%) Exhibits225: Chart on South Africa - Market size and forecast 2025-2030 ($ million) Exhibits226: Data Table on South Africa - Market size and forecast 2025-2030 ($ million) Exhibits227: Chart on South Africa - Year-over-year growth 2025-2030 (%) Exhibits228: Data Table on South Africa - Year-over-year growth 2025-2030 (%) Exhibits229: Chart on UAE - Market size and forecast 2025-2030 ($ million) Exhibits230: Data Table on UAE - Market size and forecast 2025-2030 ($ million) Exhibits231: Chart on UAE - Year-over-year growth 2025-2030 (%) Exhibits232: Data Table on UAE - Year-over-year growth 2025-2030 (%) Exhibits233: Chart on Chile - Market size and forecast 2025-2030 ($ million) Exhibits234: Data Table on Chile - Market size and forecast 2025-2030 ($ million) Exhibits235: Chart on Chile - Year-over-year growth 2025-2030 (%) Exhibits236: Data Table on Chile - Year-over-year growth 2025-2030 (%) Exhibits237: Chart on Turkey - Market size and forecast 2025-2030 ($ million) Exhibits238: Data Table on Turkey - Market size and forecast 2025-2030 ($ million) Exhibits239: Chart on Turkey - Year-over-year growth 2025-2030 (%) Exhibits240: Data Table on Turkey - Year-over-year growth 2025-2030 (%) Exhibits241: Market opportunity by geography ($ million) Exhibits242: Data Tables on Market opportunity by geography ($ million) Exhibits243: Impact of drivers and challenges in 2025 and 2030 Exhibits244: Overview on criticality of inputs and factors of differentiation Exhibits245: Overview on factors of disruption Exhibits246: Impact of key risks on business Exhibits247: Companies covered Exhibits248: Company ranking index Exhibits249: Matrix on companies position and classification Exhibits250: AbbVie Inc. - Overview Exhibits251: AbbVie Inc. - Business segments Exhibits252: AbbVie Inc. - Key news Exhibits253: AbbVie Inc. - Key offerings Exhibits254: AbbVie Inc. - Segment focus Exhibits255: SWOT Exhibits256: Amgen Inc. - Overview Exhibits257: Amgen Inc. - Product / Service Exhibits258: Amgen Inc. - Key news Exhibits259: Amgen Inc. - Key offerings Exhibits260: SWOT Exhibits261: AstraZeneca Plc - Overview Exhibits262: AstraZeneca Plc - Business segments Exhibits263: AstraZeneca Plc - Key news Exhibits264: AstraZeneca Plc - Key offerings Exhibits265: AstraZeneca Plc - Segment focus Exhibits266: SWOT Exhibits267: Bayer AG - Overview Exhibits268: Bayer AG - Business segments Exhibits269: Bayer AG - Key news Exhibits270: Bayer AG - Key offerings Exhibits271: Bayer AG - Segment focus Exhibits272: SWOT Exhibits273: Bristol Myers Squibb Co. - Overview Exhibits274: Bristol Myers Squibb Co. - Product / Service Exhibits275: Bristol Myers Squibb Co. - Key news Exhibits276: Bristol Myers Squibb Co. - Key offerings Exhibits277: SWOT Exhibits278: Daiichi Sankyo Co. Ltd. - Overview Exhibits279: Daiichi Sankyo Co. Ltd. - Business segments Exhibits280: Daiichi Sankyo Co. Ltd. - Key news Exhibits281: Daiichi Sankyo Co. Ltd. - Key offerings Exhibits282: Daiichi Sankyo Co. Ltd. - Segment focus Exhibits283: SWOT Exhibits284: Eli Lilly and Co. - Overview Exhibits285: Eli Lilly and Co. - Product / Service Exhibits286: Eli Lilly and Co. - Key news Exhibits287: Eli Lilly and Co. - Key offerings Exhibits288: SWOT Exhibits289: F. Hoffmann La Roche Ltd. - Overview Exhibits290: F. Hoffmann La Roche Ltd. - Business segments Exhibits291: F. Hoffmann La Roche Ltd. - Key news Exhibits292: F. Hoffmann La Roche Ltd. - Key offerings Exhibits293: F. Hoffmann La Roche Ltd. - Segment focus Exhibits294: SWOT Exhibits295: GlaxoSmithKline Plc - Overview Exhibits296: GlaxoSmithKline Plc - Business segments Exhibits297: GlaxoSmithKline Plc - Key news Exhibits298: GlaxoSmithKline Plc - Key offerings Exhibits299: GlaxoSmithKline Plc - Segment focus Exhibits300: SWOT Exhibits301: Johnson and Johnson - Overview Exhibits302: Johnson and Johnson - Business segments Exhibits303: Johnson and Johnson - Key news Exhibits304: Johnson and Johnson - Key offerings Exhibits305: Johnson and Johnson - Segment focus Exhibits306: SWOT Exhibits307: Merck KGaA - Overview Exhibits308: Merck KGaA - Business segments Exhibits309: Merck KGaA - Key news Exhibits310: Merck KGaA - Key offerings Exhibits311: Merck KGaA - Segment focus Exhibits312: SWOT Exhibits313: Novartis AG - Overview Exhibits314: Novartis AG - Business segments Exhibits315: Novartis AG - Key news Exhibits316: Novartis AG - Key offerings Exhibits317: Novartis AG - Segment focus Exhibits318: SWOT Exhibits319: Pfizer Inc. - Overview Exhibits320: Pfizer Inc. - Business segments Exhibits321: Pfizer Inc. - Key news Exhibits322: Pfizer Inc. - Key offerings Exhibits323: Pfizer Inc. - Segment focus Exhibits324: SWOT Exhibits325: Sanofi SA - Overview Exhibits326: Sanofi SA - Business segments Exhibits327: Sanofi SA - Key news Exhibits328: Sanofi SA - Key offerings Exhibits329: Sanofi SA - Segment focus Exhibits330: SWOT Exhibits331: Takeda Pharmaceutical Ltd. - Overview Exhibits332: Takeda Pharmaceutical Ltd. - Business segments Exhibits333: Takeda Pharmaceutical Ltd. - Key news Exhibits334: Takeda Pharmaceutical Ltd. - Key offerings Exhibits335: Takeda Pharmaceutical Ltd. - Segment focus Exhibits336: SWOT Exhibits337: Inclusions checklist Exhibits338: Exclusions checklist Exhibits339: Currency conversion rates for US$ Exhibits340: Research methodology Exhibits341: Information sources Exhibits342: Data validation Exhibits343: Validation techniques employed for market sizing Exhibits344: Data synthesis Exhibits345: 360 degree market analysis Exhibits346: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
TechNavio社の Health Care分野 での最新刊レポート
本レポートと同じKEY WORD(oncology)の最新刊レポート
よくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|